STOCK TITAN
  1. Home
  2. Sec-filings
  3. ABEO
  4. [8-K] Abeona Therapeutics Inc. Reports Material Event

[8-K] Abeona Therapeutics Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ABEO logo
Abeona Therapeut

NASDAQ:ABEO

ABEO Rankings

#3675 Ranked by Market Cap
N/A Ranked by Dividends

ABEO Latest News

Sep 2, 2025
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 29, 2025
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
Aug 14, 2025
Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates
Aug 1, 2025
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 15, 2025
ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area

ABEO Latest SEC Filings

Aug 15, 2025
[Form 4] Abeona Therapeutics Inc. Insider Trading Activity
Aug 15, 2025
[Form 4] Abeona Therapeutics Inc. Insider Trading Activity
Aug 15, 2025
[144] Abeona Therapeutics Inc. SEC Filing
Aug 14, 2025
[10-Q] Abeona Therapeutics Inc. Quarterly Earnings Report
Aug 14, 2025
[8-K] Abeona Therapeutics Inc. Reports Material Event

ABEO Stock Data

334.85M
48.31M
5.78%
73.58%
17.61%
Biotechnology
Pharmaceutical Preparations
Link
United States
CLEVELAND